A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D Patients
IsraelRecruiting
Conditions
Type 1 Diabetes · Autoantibodies Screening
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Schneider Children Medical Center of Israel, Petah Tikva, Israel
Contact: Principal Investigator (Moshe Phillip, Prof)Tal Oron, Dr. (Sub-investigator)
Study leads
Moshe Phillip, Prof.
Principal Investigator
Schneider Children's Medical Center